Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esaxerenone in Type 2 Diabetes Mellitus Patients with Hypertension on SGLT2 Inhibitors
jRCTs031200273Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esaxerenone in hypertension (HTN), type 2 diabetes mellitus (T2DM) and diabetic glomerulosclerosis, sponsored by Daiichi Sankyo Co., Ltd. Started Jan 2021; status: completed.
02
Drugs
esaxerenone
03
Conditions
hypertension (HTN)type 2 diabetes mellitus (T2DM)diabetic glomerulosclerosis
Beyond the preview
Go deeper on jRCTs031200273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031200273.